Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
CAI
— Caris Life Sciences, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
FEB 27, 2026
REVENUE
$292.9M
+35.1%
NET MARGIN
28.0%
+16.8 PTS
EPS
$0.29
+237.2%
FREE CASH FLOW
$39.7M
-28.3%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →